The new EPiC (Engineered Plants in Culture) project at UC Davis will explore technology for growing plants and plant tissues in bioreactors with minimal use of resources. The technology could be used ...

DUBLIN--(BUSINESS WIRE)--The "Digital Biomanufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Technology, Deployment Options, Type of Biologics and Key Geographical Regions" ...

Jerry Keybl is senior vice president, biopharma products and strategy at Avantor. Ahead of this year’s Interphex meeting in New York City, Jerry Keybl, Avantor’s senior vice president, biopharma ...

Construction technology encompasses a range of modern equipment, machinery, software and modifications. Using sustainable construction technologies can greatly lessen the negative impact of buildings ...

Our planet faces an urgent environmental and social crisis, but hope could be on the horizon. Biomanufacturing offers a revolutionary solution for improving the sustainability and responsibility of ...

The report states that the next step “is to coordinate efforts across government to address these proposed actions, such as through the National Bioeconomy Board.” The report suggests that this could ...

Cell culture media, novel resin technologies, and single-use systems are among the most active areas of R&D in the biomanufacturing sector. GEN recently interviewed several scheduled speakers for the ...

The use of living organisms and biological components in manufacturing processes is increasing across domestic and international manufacturing sectors. The role of biomanufacturing will continue to ...

Researchers have succeeded in biomanufacturing from chemically synthesized sugar for the first time in the world. With refinement of this technology, one can envision a future society in which the ...

As America prepares for a new Congress and administration, the nation stands at a crossroads of opportunity. President-elect Donald Trump’s commitment to revitalizing American industry comes at a ...

Talk of a slowdown in life sciences funding and investment hasn’t changed the plans of pharma giant Eli Lilly. The Indianapolis-based biotech giant just announced an additional $1.6B investment in its ...